Compare RDY & ESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | ESI |
|---|---|---|
| Founded | 1984 | 1922 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 9.2B |
| IPO Year | 2001 | 2014 |
| Metric | RDY | ESI |
|---|---|---|
| Price | $14.92 | $30.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | $14.79 | ★ $47.33 |
| AVG Volume (30 Days) | 2.4M | ★ 4.0M |
| Earning Date | 10-23-2026 | 10-21-2026 |
| Dividend Yield | 0.43% | ★ 1.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $2,551,200,000.00 |
| Revenue This Year | $4.58 | $48.33 |
| Revenue Next Year | $11.95 | $8.01 |
| P/E Ratio | ★ $18.67 | $39.07 |
| Revenue Growth | N/A | ★ 3.84 |
| 52 Week Low | $11.36 | $24.40 |
| 52 Week High | $15.67 | $49.25 |
| Indicator | RDY | ESI |
|---|---|---|
| Relative Strength Index (RSI) | 68.25 | 35.86 |
| Support Level | $12.91 | N/A |
| Resistance Level | $15.08 | $37.15 |
| Average True Range (ATR) | 0.26 | 1.45 |
| MACD | -0.04 | -0.18 |
| Stochastic Oscillator | 78.74 | 5.85 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.